Magnesium for Spinal Surgery
(MgNm Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial aims to study how magnesium, a common mineral, affects monitoring during spinal surgery. Specifically, it examines its impact on Transcranial Motor Evoked Potentials, which help surgeons ensure the safety of motor pathways during the operation. The trial will explore whether magnesium can manage pain and reduce opioid use without interfering with surgery monitoring. Adults undergoing complex spinal surgery with planned neuromonitoring and no major heart, kidney, or liver issues may be eligible to participate. As a Phase 4 trial, this research involves an FDA-approved treatment and seeks to understand how magnesium can benefit more patients.
Will I have to stop taking my current medications?
The trial information does not specify if you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.
What is the safety track record for this treatment?
Research has shown that magnesium, often used in spinal surgery, is generally safe. Studies have found that magnesium can help reduce pain and the need for painkillers after surgery. It also seems to lower the chances of nausea and shivering during the operation.
In previous studies, participants who received magnesium did not report serious side effects, suggesting it is usually well-tolerated. Magnesium has been used in medicine for a long time, providing extensive knowledge about its safety. However, this trial will specifically examine how magnesium affects a type of nerve monitoring during surgery.
Overall, magnesium appears to be a safe option for many patients undergoing spinal surgeries.12345Why are researchers enthusiastic about this study treatment?
Researchers are excited about using magnesium for spinal surgery because it offers a novel approach to managing pain and recovery. Unlike standard treatments that often rely on opioids or other pain medications, magnesium works by modulating neural excitability and reducing inflammation, which could potentially reduce the need for conventional painkillers. Additionally, the delivery method is unique—a single intravenous bolus administered quickly—which may offer faster relief and fewer side effects compared to prolonged drug regimens. Overall, magnesium's potential to enhance recovery while minimizing opioid use is what makes it stand out in the treatment landscape for spinal surgery.
What evidence suggests that magnesium is effective for spinal surgery?
Research has shown that magnesium, which participants in this trial will receive, can reduce pain and the need for strong painkillers after spinal surgery. Studies have found that magnesium not only eases post-surgery pain but also helps with nausea and vomiting. It blocks certain signals in the brain that cause pain. Additionally, magnesium shows promise for pain relief during surgery by helping the body manage stress. It has been safely used for many years in medical practice and effectively manages pain in spinal surgeries.12345
Who Is on the Research Team?
Hemra Cil, MD
Principal Investigator
University of California, San Francisco
Are You a Good Fit for This Trial?
This trial is for individuals undergoing complex spinal surgery who can be monitored using a technique called Transcranial Motor Evoked Potentials (TcMEPs). Participants should not have conditions that interfere with TcMEP monitoring or magnesium administration.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive a single intravenous bolus of magnesium during spinal surgery, with neuromonitoring and blood sampling for pharmacokinetics
Follow-up
Participants are monitored for safety and effectiveness after treatment, with ongoing data collection on neuromonitoring and magnesium levels
What Are the Treatments Tested in This Trial?
Interventions
- Magnesium
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of California, San Francisco
Lead Sponsor